glp-1/gip agonists Dual GIP/GLP-1 receptor agonists: New advances for treating type-2 diabetes New Weight-Loss Drugs Are Poised

Description

MECHANISM OF ACTION GLP-1 analogs Glucagon-like peptide-1 (GLP-1) is a hormone secreted into the bloodstream by special cells in the intestine in response to food consumption

This study aims to explore this gap by utilizing data from the large community-based database, TriNetX, to investigate the association between GLP-1 RA use and the risk of psychiatric diseases, including major depression, anxiety and suicidal behaviour in patients with obesity

Insulin resistance exacerbates Alzheimer disease via multiple mechanisms

Glucagon-like peptide 1 receptor agonists potential game changers in the treatment of glaucoma

Overall, a meta-analysis of RCTs showed that A1c reductions were 0.28%, 0.21%, and 0.17% for liraglutide 1.8, 1.2, and 0.6 to 0.9 mg, respectively, and 0.17% for exenatide (62)